Just been looking at this potential investment , IMO there are significant gaps in terms of the company providing any actual data or evidence to support any of the product claims that is works at all, or works faster than a tablet. A patent does not do this. They quote some unpublished in-house data that appears very loose ?
Also, I have been under the management of a urologists for prostate cancer last year and after the surgery he got a local chemist to make up a Tadalafil gummy for me because he wanted a different dose to the current tablet . They gave me this as a tiny gummy under my tongue and it seemed to work for me about the same as the tablet, but still made me feel a bit sick in the stomach, so why would you bother putting hard earned into this ? .
Also the product for period pain is basically a health food supplement.
Surely the ASX governance process must pick up on some of these gaps ?
IMO and do your own research
Add to My Watchlist
What is My Watchlist?
